|
DRG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.19310000000506E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.427900E-04 |
| Normal-vs-Stage2 |
5.807500E-02 |
| Normal-vs-Stage3 |
1.364530E-04 |
| Normal-vs-Stage4 |
2.06249999967767E-07 |
| Stage1-vs-Stage2 |
9.217200E-01 |
| Stage1-vs-Stage3 |
3.207600E-01 |
| Stage1-vs-Stage4 |
6.203800E-03 |
| Stage2-vs-Stage3 |
5.052000E-01 |
| Stage2-vs-Stage4 |
4.074500E-02 |
| Stage3-vs-Stage4 |
4.418100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89010000000356E-05 |
| Normal-vs-AfricanAmerican |
2.566100E-02 |
| Normal-vs-Asian |
2.788300E-02 |
| Caucasian-vs-AfricanAmerican |
5.720600E-01 |
| Caucasian-vs-Asian |
4.238800E-01 |
| AfricanAmerican-vs-Asian |
3.432400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.630100E-04 |
| Normal-vs-Female |
6.44779999999789E-05 |
| Male-vs-Female |
9.438600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.084210E-03 |
| Normal-vs-Age(41-60Yrs) |
1.786460E-04 |
| Normal-vs-Age(61-80Yrs) |
8.38020000000217E-05 |
| Normal-vs-Age(81-100Yrs) |
1.738240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.115200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.646400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.330200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.805000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.260000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.176200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.276400E-01 |
| Classical-VS-Follicular |
2.411800E-01 |
| Classical-VS-Other |
9.354400E-01 |
| Classical-VS-Normal |
4.435500E-04 |
| Tall-VS-Follicular |
9.168200E-01 |
| Tall-VS-Other |
8.404800E-01 |
| Tall-VS-Normal |
1.835960E-04 |
| Follicular-VS-Other |
8.127200E-01 |
| Follicular-VS-Normal |
7.784200E-04 |
| Other-VS-Normal |
5.030600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.025600E-04 |
| Normal-vs-N1 |
3.354199999972E-06 |
| N0-vs-N1 |
4.717700E-02 |
|
|
